IL165129A0 - Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm - Google Patents
Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a sermInfo
- Publication number
- IL165129A0 IL165129A0 IL16512904A IL16512904A IL165129A0 IL 165129 A0 IL165129 A0 IL 165129A0 IL 16512904 A IL16512904 A IL 16512904A IL 16512904 A IL16512904 A IL 16512904A IL 165129 A0 IL165129 A0 IL 165129A0
- Authority
- IL
- Israel
- Prior art keywords
- pateins
- tibolone
- serm
- post
- treatment
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- WZDGZWOAQTVYBX-XOINTXKNSA-N tibolone Chemical compound C([C@@H]12)C[C@]3(C)[C@@](C#C)(O)CC[C@H]3[C@@H]1[C@H](C)CC1=C2CCC(=O)C1 WZDGZWOAQTVYBX-XOINTXKNSA-N 0.000 title 1
- 229960001023 tibolone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02077050 | 2002-05-24 | ||
PCT/EP2003/050178 WO2003099292A1 (en) | 2002-05-24 | 2003-05-20 | Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm |
Publications (1)
Publication Number | Publication Date |
---|---|
IL165129A0 true IL165129A0 (en) | 2005-12-18 |
Family
ID=29558370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16512904A IL165129A0 (en) | 2002-05-24 | 2004-11-09 | Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050222100A1 (es) |
EP (1) | EP1511497A1 (es) |
JP (1) | JP2005531575A (es) |
KR (1) | KR20050005490A (es) |
CN (1) | CN1655796A (es) |
AR (1) | AR039843A1 (es) |
AU (1) | AU2003273170A1 (es) |
BR (1) | BR0311146A (es) |
CA (1) | CA2487268A1 (es) |
IL (1) | IL165129A0 (es) |
MX (1) | MXPA04011687A (es) |
PE (1) | PE20031047A1 (es) |
TW (1) | TW200307553A (es) |
WO (1) | WO2003099292A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2234060A1 (en) * | 1995-10-06 | 1997-04-10 | Arch Development Corporation | Methods and compositions for viral enhancement of cell killing |
CA2654152A1 (en) | 2006-06-02 | 2007-12-13 | Pear Tree Women's Health Care | Method of treating atrophic vaginitis |
EP2037905B1 (en) * | 2006-06-23 | 2013-05-01 | Radius Health, Inc. | Treatment of vasomotor symptoms with selective estrogen receptor modulators |
WO2009137104A1 (en) * | 2008-05-09 | 2009-11-12 | Radius Health, Inc. | Combination therapy for breastcancer comprising an antiestrogenic agent |
DE102008057230A1 (de) * | 2008-11-11 | 2010-05-12 | Bayer Schering Pharma Aktiengesellschaft | Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin |
MX342898B (es) | 2010-05-12 | 2016-10-18 | Radius Health Inc * | Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol. |
BR112013007685B1 (pt) | 2010-09-28 | 2021-11-09 | Radius Pharmaceuticals, Inc | Compostos moduladores de receptor andrógeno seletivos, composição farmacêutica compreendendo os referidos compostos, método de identificação de um composto capaz de modular um receptor andrógeno, usos de um composto ou da composição e processo para a preparação de um composto |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
DK3122426T3 (da) | 2014-03-28 | 2023-04-03 | Univ Duke | Behandling af brystcancer ved anvendelse af selektive østrogenreceptormodulatorer |
EP4039253A1 (en) | 2015-04-29 | 2022-08-10 | Radius Pharmaceuticals, Inc. | Methods of treating cancer |
AU2017281038B2 (en) | 2016-06-22 | 2021-09-09 | Ellipses Pharma Ltd | AR+ breast cancer treatment methods |
KR20230109795A (ko) | 2017-01-05 | 2023-07-20 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
SG11202013177WA (en) | 2018-07-04 | 2021-01-28 | Radius Pharmaceuticals Inc | Polymorphic forms of rad 1901-2hcl |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1251855A1 (en) * | 2000-01-28 | 2002-10-30 | Endorecherche, Inc. | Selective estrogen receptor modulators in combination with estrogens |
US6756480B2 (en) * | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
IL158871A0 (en) * | 2001-07-31 | 2004-05-12 | Pfizer Prod Inc | Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
-
2003
- 2003-05-16 TW TW092113384A patent/TW200307553A/zh unknown
- 2003-05-20 CN CNA038118041A patent/CN1655796A/zh active Pending
- 2003-05-20 JP JP2004506816A patent/JP2005531575A/ja active Pending
- 2003-05-20 CA CA002487268A patent/CA2487268A1/en not_active Abandoned
- 2003-05-20 US US10/515,712 patent/US20050222100A1/en not_active Abandoned
- 2003-05-20 MX MXPA04011687A patent/MXPA04011687A/es unknown
- 2003-05-20 KR KR10-2004-7018936A patent/KR20050005490A/ko not_active Application Discontinuation
- 2003-05-20 PE PE2003000493A patent/PE20031047A1/es not_active Application Discontinuation
- 2003-05-20 WO PCT/EP2003/050178 patent/WO2003099292A1/en active Application Filing
- 2003-05-20 AU AU2003273170A patent/AU2003273170A1/en not_active Abandoned
- 2003-05-20 EP EP03740483A patent/EP1511497A1/en not_active Withdrawn
- 2003-05-20 BR BR0311146-6A patent/BR0311146A/pt not_active IP Right Cessation
- 2003-05-22 AR ARP030101779A patent/AR039843A1/es not_active Application Discontinuation
-
2004
- 2004-11-09 IL IL16512904A patent/IL165129A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20050005490A (ko) | 2005-01-13 |
US20050222100A1 (en) | 2005-10-06 |
AR039843A1 (es) | 2005-03-02 |
CA2487268A1 (en) | 2003-12-04 |
EP1511497A1 (en) | 2005-03-09 |
BR0311146A (pt) | 2005-03-15 |
CN1655796A (zh) | 2005-08-17 |
TW200307553A (en) | 2003-12-16 |
AU2003273170A1 (en) | 2003-12-12 |
PE20031047A1 (es) | 2003-12-23 |
WO2003099292A1 (en) | 2003-12-04 |
JP2005531575A (ja) | 2005-10-20 |
MXPA04011687A (es) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL165129A0 (en) | Treatment of post-menopausal complaints in breast cancer pateins comprising tibolone and a serm | |
HK1127544A1 (en) | Repositioning apparatus and garment | |
HK1078007A1 (en) | Pramipexole once-daily dosage form | |
ZA200500432B (en) | Sustained-release tablet comprising reboxetine | |
EP1565187A4 (en) | CANCER TREATMENT METHODS AND RELATED METHODS | |
HK1119950A1 (en) | Formulations for prevention and treatment of breast cancer with 4-hydroxy tamoxifen 4- | |
IL163734A (en) | Shaped tampon | |
EP1482970A4 (en) | ANTICANCER THERAPY | |
IL164211A0 (en) | Il-18 inhibitors and peripheral vascular diseases | |
AU2003236211A8 (en) | Smac-peptides as therapeutics against cancer and autoimmune diseases | |
AU2003255544A8 (en) | Tumor specific oligosaccharide epitopes and use thereof | |
GB0005257D0 (en) | Breast cancer hormonal therapy | |
GB0207410D0 (en) | Compounds and their therapeutic use | |
AU2003293130A8 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
IL165725A0 (en) | Immunotoxin as a therapeutic agent and uses thereof | |
AU2003231803A8 (en) | Treatment of cancer with mefloquire | |
AU2002360815A8 (en) | Human breast cancer biomarkers | |
GB0207409D0 (en) | Benzofuran-2H-3-one compounds and their therapeutic use | |
HK1080716A1 (en) | A use of desmethylselegiline in manufacture of medicine for preventing and treating peripheral neuropathy | |
GB0325613D0 (en) | Therapeutic and prophylactic preparations | |
AU2003298742A8 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
SI1427420T1 (sl) | Uporaba kombinacije, ki vsebuje 4-piridilmetilftalazine za zdravljenje raka | |
GB0205826D0 (en) | Therapeutic compositions and methods | |
IL164099A0 (en) | Use of interleukin-19 to treat cervical cancer | |
GB2385526B (en) | Sanitary pad |